HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SHU 508 (Levovist)

intravenous saccharide echo contrast agent with transpulmonary capacity for left heart contrast; appears in Japanese literature as SH/TA-508
Also Known As:
Levovist; SH-TA-508; SHU 508 A; SHU-508
Networked: 203 relevant articles (20 outcomes, 43 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yamamoto, Kouji: 6 articles (01/2006 - 07/2002)
2. Nakano, Takeshi: 5 articles (10/2005 - 07/2002)
3. Shimizu, Atsuya: 5 articles (10/2005 - 07/2002)
4. Shiraki, Katsuya: 5 articles (10/2005 - 07/2002)
5. Hashimoto, Akira: 5 articles (10/2005 - 07/2002)
6. Moriyasu, Fuminori: 4 articles (03/2012 - 05/2005)
7. Kondo, Takashi: 4 articles (06/2008 - 05/2002)
8. Nakanishi, Shigeo: 4 articles (10/2005 - 02/2003)
9. Fuke, Hiroyuki: 4 articles (10/2005 - 02/2003)
10. Kudo, Masatoshi: 3 articles (07/2010 - 07/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Hepatocellular Carcinoma (Hepatoma)
3. Neoplasm Metastasis (Metastasis)
4. Mitral Valve Insufficiency (Mitral Regurgitation)
5. Carcinoma (Carcinomatosis)

Related Drugs and Biologics

1. Colloids (Colloid)
2. Contrast Media
3. glucuronyl glucosamine glycan sulfate (Vessel)
4. Galactose (Galactopyranose)
5. Ethanol (Ethyl Alcohol)
6. 3-chloro-4,4-dimethyl-2-oxazolidinone (agent I)
7. FS 069 (Optison)
8. contrast agent BR1
9. SHU 508 (Levovist)
10. Palmitic Acid (Hexadecanoic Acid)

Related Therapies and Procedures

1. Microbubbles
2. Intravenous Injections
3. Catheters
4. Intravenous Infusions
5. Infusion Pumps (Infusion Pump)